BIO vs TCMD · rev $651.0M vs P/E 30, rev $161.0M
BIO (BIO) versus Tactile Systems Technology Inc (TCMD) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Tactile Systems Technology Inc (TCMD) is a medical devices company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported TCMD revenue for 2026-06-30 was $161.0M. Net income was $6.0M. TCMD currently screens at market cap $590.1M and trailing P/E 30.1.
BIO currently screens at market cap $0. TCMD currently screens at market cap $590.1M and trailing P/E 30.1.
Not investment advice. Open the BIO and TCMD stock pages for the full models.
Not investment advice.